BISODOL ANTACID 522/68/64 Milligram Tablets Chewable

Pays: Irlande

Langue: anglais

Source: HPRA (Health Products Regulatory Authority)

Achète-le

Ingrédients actifs:

SODIUM BICARBONATE, CALCIUM CARBONATE, LIGHT MAGNESIUM CARBONATE

Disponible depuis:

Forest Laboratories UK Ltd

Code ATC:

A02AC01

DCI (Dénomination commune internationale):

SODIUM BICARBONATE, CALCIUM CARBONATE, LIGHT MAGNESIUM CARBONATE

Dosage:

522/68/64 Milligram

forme pharmaceutique:

Tablets Chewable

Type d'ordonnance:

Product not subject to medical prescription

Domaine thérapeutique:

Calcium compounds

Statut de autorisation:

Authorised

Date de l'autorisation:

2003-04-01

Notice patient

                                dimensions: 117 x 320 
pharmacode: 
date sent: 30.07.15
TECHNICAL APPROVAL
min pt size: 8pt 
1. black
2. pms 286 
3. pms 288 
4. pms 2995 
5. 
6. 
1. Profile
2. 
Bisodol Original Peppermint 522mg, 68mg 64mg 100 Tablets PIL -
Ireland
item no: AAAI1732
print proof no: 06
origination date: 30.07.15
originated by: DR
revision date: 25-08-2015
supplier: Brunel Healthcare
technically app. date:  
Non Printing Colours
colours/plates
3.  
revised by: SA
approved for print/date
BISODOL® ANTACID CHEWABLE TABLETS
Calcium Carbonate 522 mg, Magnesium Carbonate, Light 68 mg, 
Sodium Hydrogen Carbonate 64 mg.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS 
MEDICINE, BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
This medicine is available without prescription. However, you still 
need to take Bisodol Antacid Tablets carefully to get the best 
results.
•  Always use this medicine exactly as your doctor or pharmacist 
has told you.
•  Keep this leaflet. You may need to read it again.
•  Ask your pharmacist if you need more information or advice.
•  If you get any side effects, talk to your doctor, pharmacist
or 
nurse. This includes any possible side effects not listed in this 
leaflet. See section 4.
•  You must contact a doctor if your signs of illness worsen or
do 
not improve.
 WHAT IS IN THIS LEAFLET:
1. What Bisodol Antacid Chewable Tablets are and what they are 
used for
2. What you need to know before you take Bisodol Antacid 
Chewable Tablets
3. How to take Bisodol Antacid Chewable Tablets
4. Possible side effects
5. How to store Bisodol Antacid Chewable Tablets
6. Contents of the pack and other information
1. WHAT BISODOL ANTACID CHEWABLE TABLETS ARE AND WHAT THEY
ARE USED FOR
Bisodol Antacid Tablets are chewable tablets. They work by 
neutralising excess stomach acid. 
Bisodol Antacid Tablets treat the pain and discomfort of acid 
indigestion, heartburn and trapped wind.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE BISODOL ANTACID 
CHEWABLE TABLETS
DO NOT T
                                
                                Lire le document complet
                                
                            

Résumé des caractéristiques du produit

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Bisodol Antacid Chewable Tablets
Calcium Carbonate 522mg
Magnesium Carbonate Light 68mg
Sodium Hydrogen Carbonate 64mg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each chewable tablet contains:
64 mg of Sodium Hydrogen Carbonate
522 mg of Calcium Carbonate
68 mg of Magnesium Carbonate, Light
Excipients with known effect:
Each chewable tablet also contains 538.3mg of sucrose
Each chewable tablets also contains 18mg of sodium
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Chewable Tablet
Circular, smooth white bevel-edged tablet marked Bisodol on both sides.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
In the relief of symptoms of indigestion, dyspepsia, heartburn, acidity and flatulence.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults_
Two tablets as required.
_Paediatric population_
Children under 12 years: not recommended
Do not take more than 12 tablets in 24 hours.
Method of administration
Bisodol Chewable Tablets are to be administered orally
4.3 CONTRAINDICATIONS
Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 07/12/2015_
_CRN 2164483_
_page number: 1_
Hypophosphataemia. Avoid in patients with renal failure.
Hypercalcaemia and hypercalciuria.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Magnesium salts may cause central nervous depression in the presence of renal insufficiency.
Persons with kidney disease or receiving medical treatment should consult their doctor before using.
Prolonged use should be avoided. If the symptoms persist, medical advice should be sought.
Do not exceed the stated dose ex
                                
                                Lire le document complet